Search

AF solution

Chevron

Advances in Organoids: From Personalized Cancer Therapy to Tissue Regeneration

Paper Title: DNA Microbeads for Spatio-Temporal Control in Organoids

Journal: Nature Nanotechnology

Author: Cassian Afting, Heidelberg University, Germany 1-sentence

Summary: The paper introduces DNA microbeads for spatial control in organoid formation.

This study presents a technique using DNA microbeads to control morphogen release in organoids, enabling the precise development of complex tissues. This has significant potential in tissue engineering and regenerative medicine.

Paper Title: Tumor Organoids for Personalized Cancer Therapy

Journal: Journal of Hematology & Oncology

Author: AFM Dost, UK

Summary: The study explores tumor organoids for personalized cancer treatment.

The paper uses tumor organoids to study early molecular events in cancer and offers insights into personalized cancer treatments by focusing on KRAS mutations. This highlights organoids as a precision medicine tool.

Paper Title: Organoid Models for Liver Cancer Research

Journal: Cell & Bioscience

Author: Miho, Japan

Summary: The study develops liver cancer organoids for research and treatment.

This paper creates liver cancer organoids that mimic human liver tissue, enabling studies of cancer mechanisms and drug responses. It opens new possibilities for liver cancer treatment and drug testing.

Paper Title: Synthetic Biology in Tissue Regeneration

Journal: Nature Aging

Author: Xiaotao Shen, Ph.D

Summary: A study published in September 2024 revealed that individuals experience significant molecular and microbial shifts in their mid-40s and early 60s.

The researchers tracked over 135,000 molecules and microbes, discovering non-linear changes linked to aging. These shifts, particularly in cardiovascular disease and immune function markers, could influence disease risks during these critical periods.

Connect with Us

By submitting your details, you confirm that you have reviewed and agree with the Lambda Biologics Privacy Policy.